β-Hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells (Retraction of vol 109, pg 107, 2008)

被引:0
|
作者
Takai, Noriyuki [1 ]
Ueda, Tami [1 ]
Nishida, Masakazu [1 ]
Nasu, Kaei [1 ]
Narahara, Hisashi [1 ]
机构
[1] Oita Univ, Dept Obstet & Gynecol, Fac Med, Oita 87011, Japan
关键词
D O I
10.1016/j.ygyno.2012.09.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:269 / 269
页数:1
相关论文
共 50 条
  • [1] RETRACTED: β-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells (Retracted Article)
    Takai, Noriyuki
    Ueda, Tami
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2008, 109 (01) : 107 - 114
  • [2] Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells
    Ueda, Tami
    Takai, Noriyuki
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (02) : 301 - 308
  • [3] Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells (vol 111, pg 336, 2008)
    Takai, Noriyuki
    Ueda, Tami
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2013, 129 (01) : 268 - 268
  • [4] Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells (Retraction of vol 297, pg 198, 2010)
    Li, Haili
    Takai, Noriyuki
    Yuge, Akitoshi
    Furukawa, Yuichi
    Tsuno, Akitoshi
    Tsukamoto, Yoshiyuki
    Kong, Shigi
    Moriyama, Masatsugu
    Narahara, Hisashi
    CANCER LETTERS, 2013, 338 (02) : 331 - 331
  • [5] RETRACTED: Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells (Retracted Article)
    Takai, Noriyuki
    Ueda, Tami
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 336 - 343
  • [6] SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells
    Komatsu, N
    Kawamata, N
    Takeuchi, S
    Yin, D
    Chien, WW
    Miller, CW
    Koeffler, HP
    ONCOLOGY REPORTS, 2006, 15 (01) : 187 - 191
  • [7] RETRACTED: Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells (Retracted article. See vol. 338, pg. 331, 2013)
    Li, Haili
    Takai, Noriyuki
    Yuge, Akitoshi
    Furukawa, Yuichi
    Tsuno, Akitoshi
    Tsukamoto, Yoshiyuki
    Kong, Shigi
    Moriyama, Masatsugu
    Narahara, Hisashi
    CANCER LETTERS, 2010, 297 (02) : 198 - 206
  • [8] RETRACTION: Knockdown of AQP1 inhibits growth and invasion of human ovarian cancer cells (Retraction of Vol 16, Pg 5499, 2017)
    Wang, Yanli
    Fan, Yanyan
    Zheng, Chunhua
    Zhang, Xiaomeng
    MOLECULAR MEDICINE REPORTS, 2021, 24 (06)
  • [9] Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells (vol 107, pg 1038, 2003)
    Um, SJ
    Han, HS
    Kwon, YJ
    Park, SH
    Rho, YS
    Sin, HS
    Park, JS
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) : 945 - 945
  • [10] RETRACTION: Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors (Retraction of Vol 71, Pg 283, 2011)
    Morgillo, Floriana
    D'Aiuto, Elena
    Troiani, Teresa
    Martinelli, Erika
    Cascone, Tina
    De Palma, Raffaele
    Orditura, Michele
    De Vita, Ferdinando
    Ciardiello, Fortunato
    LUNG CANCER, 2023, 181